PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, reports that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.'s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix's operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

**************************************************************

Sapiens International Corporation N.V. (Nasdaq:SPNS), a global provider of innovative insurance software solutions, reports that Philadelphia Insurance Companies has deployed the RapidSure Policy Administration solution for the first phase of replacing and improving their policy issuance processes and systems. Development of additional lines is already underway for the second phase of the project. RapidSure is the policy administration system built by Harcase which was recently acquired by Sapiens.

Sapiens International Corporation N.V. is a leading global provider of business solutions for the insurance industry. Sapiens is dedicated to developing innovative insurance solutions for the ever-changing Property & Casualty, Reinsurance, and Life & Pension business environments. By leveraging innovative technology, open standards and model driven architecture, Sapiens helps insurers create their competitive advantage. Sapiens operates through its subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific.

**************************************************************

Sapient (NASDAQ: SAPE) subsidiary SapientNitro, and Jive announced that they are deepening their partnership with an increased focus and commitment to jointly develop multi-channel marketing solutions.

SapientNitro is a Gold sponsor of JiveWorld10, the social business event of the year. JiveWorld10 is taking place this week at the InterContinental Hotel in San Francisco, California. This year's event is sold out and will be more than twice the size of last year's conference.

“Leveraging the power of the social web and social communities is now seen as a critical component in today’s digital marketing solutions,” said Dan Barnicle, vice president, content management & collaboration for SapientNitro. “Jive’s depth and breadth, combined with scalability and security, makes them the obvious choice for our enterprise clients.”

Jive combines Social Business Software with social media monitoring, allowing marketers to engage with their clients and customers in a more meaningful way. Communication is two-way and real time, reducing product development lifecycles and market research costs. The Jive platform provides a rich forum for ideation, where companies can enable their customers to voice their opinions and ideas. With Jive, companies can fully leverage the social web and respond faster to discussions as they are happening on the Web.

**************************************************************

Sappi Limited (NYSE:SPP) subsidiary Sappi Fine Paper North America announced the 27 grant recipients for its 11th Ideas that Matter — an annual, innovative grant program that transforms the creative ideas of designers into a powerful force for social good. Through Ideas that Matter, each designer's project will support the mission and public awareness campaigns of a nonprofit organization of their choosing. The winning projects represent a vast array of social, cultural, and environmental issues and were selected based on their creativity, potential impact and practicality of the implementation plan, and were selected by an independent panel of judges.

Sappi Fine Paper North America is a preeminent North American producer of coated fine paper used in premium magazines, catalogues, books and high-end print advertising. Headquartered in Boston, Massachusetts, Sappi Fine Paper North America is known for innovation and quality. Its brand names, including McCoy, Opus, Somerset and Flo, are some of the industry's most widely recognized and specified. Sappi's mills in North America are triple chain of custody certified to the Forest Stewardship Council (FSC), Sustainable Forestry Initiative (SFI), and Programme for the Endorsement of Forest Certification (PEFC). Over 80 percent of the energy used by Sappi's North American mills comes from renewable resources, resulting in one of the lowest carbon footprints of any major North American coated paper supplier. Sappi Fine Paper North America is a division of Sappi Limited, a global company headquartered in Johannesburg, South Africa, with manufacturing operations on four continents in 10 countries, sales offices in over 40 countries, and customers in over 100 countries around the world.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)